Replies to post #116876 on Biotech Values

[tinkershaw]

Funny, how with the TEVA recommedation you cited, that they gave thought to the hypothetical of lovenox being approved mid-2011 but no concern at all to copaxone generic being approved at all, which would be a calamity for TEVA share price.

Nothing like a calculated bias.

Tinker